---
document_datetime: 2025-07-10 12:32:03
document_pages: 11
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/temozolomide-sun-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: temozolomide-sun-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 6.1399008
conversion_datetime: 2025-12-31 02:46:44.72809
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Temozolomide SUN

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0036              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 15/03/2022                          |                                             | SmPC and PL                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| N/0035    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                            | 06/12/2021   |            | PL                               |         |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|---------|
| IA/0034   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                               | 09/11/2021   | n/a        |                                  |         |
| IB/0033   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                                                                                                        | 10/07/2020   | 16/11/2020 | SmPC and PL                      | the MAH |
| N/0032    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                            | 11/03/2020   | 16/11/2020 | PL                               |         |
| IAIN/0031 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                              | 27/09/2019   | 16/11/2020 | SmPC, Annex II, Labelling and PL |         |
| IB/0029/G | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch | 12/04/2019   | n/a        |                                  |         |

<div style=\"page-break-after: always\"></div>

|           | size                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |            |                        |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| N/0030    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 05/04/2019 | 25/07/2019 | Labelling              |
| N/0028    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 18/10/2018 | 25/07/2019 | PL                     |
| IA/0027/G | This was an application for a group of variations. B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) | 03/08/2018 | 25/07/2019 | SmPC, Labelling and PL |

<div style=\"page-break-after: always\"></div>

|           | product - Deletion of a pack size(s) B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s)                                                                                                                                   |            |            |                        |                                                              |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------------------------------------|
| IB/0026   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 14/06/2018 | 30/07/2018 | SmPC, Labelling and PL |                                                              |
| IA/0025   | B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits                                                                                                                   | 27/09/2017 | n/a        |                        |                                                              |
| IAIN/0024 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                               | 14/07/2017 | 30/07/2018 | SmPC and PL            |                                                              |
| IAIN/0023 | B.III.2.a.1 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - AS                                                                               | 18/01/2017 | n/a        |                        |                                                              |
| N/0022    | Update of the package leaflet with revised contact details of the local representatives for Spain and Italy. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                | 19/07/2016 | 30/07/2018 | PL                     |                                                              |
| R/0019    | Renewal of the marketing authorisation.                                                                                                                                                                                                                      | 25/02/2016 | 21/04/2016 | SmPC,                  | Based on the review of data on quality, safety and efficacy, |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |            |     | Labelling and PL   | the CHMP considered that the benefit-risk balance of Temozolomide SUN in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity.   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0021   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 13/04/2016 | n/a |                    |                                                                                                                                                                                                                     |
| IB/0020/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits | 11/03/2016 | n/a |                    |                                                                                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

|           | Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)   |            |            |             | B.I.a.4.b -   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------------|
| IAIN/0018 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                    | 24/09/2015 | n/a        |             |               |
| IA/0017   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                       | 16/09/2015 | n/a        |             |               |
| IB/0016   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                       | 22/06/2015 | 28/07/2015 | SmPC and PL |               |
| IB/0015   | B.II.b.5.f - Change to in-process tests or limits applied during the manufacture of the finished product - Addition or replacement of an in-process test as a result of a safety or quality issue                                                                                                                                                  | 16/06/2015 | n/a        |             |               |
| IB/0014   | B.II.e.6.b - Change in any part of the (primary)                                                                                                                                                                                                                                                                                                   | 16/12/2014 | n/a        |             |               |

<div style=\"page-break-after: always\"></div>

|           | material not in contact with the finished formulation - Change that does not affect product information                                                                                                                                                                                                                                                                                                                                                                             |            |            |             | packaging product the   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-------------------------|
| IB/0013   | Update of section 4.8 of the SmPC to include the calculated frequency of hepatic-related disorders following adoption of the same changes for the reference product. Section 4 of the Package Leaflet was updated accordingly. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by | 14/08/2014 | 28/07/2015 | SmPC and PL | the MAH                 |
| IB/0012   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                           | 16/07/2014 | 28/07/2015 | SmPC        |                         |
|           | This was an application for a group of variations. B.I.c.z - Container closure system of the AS - Other variation B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                            | 16/07/2014 | n/a        |             | IB/0010/G               |
| IAIN/0011 | B.II.b.1.a - Replacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                                                           | 23/06/2014 | n/a        |             |                         |

<div style=\"page-break-after: always\"></div>

|           | manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                     |            |            |             |                         |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-------------------------|
| IAIN/0008 | B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings                                                                  | 12/02/2014 | 21/03/2014 | SmPC and PL |                         |
| IB/0009   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 06/02/2014 | 21/03/2014 | SmPC and PL |                         |
| IB/0007   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                    | 06/02/2014 | 21/03/2014 | SmPC        |                         |
| IAIN/0006 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                              | 26/11/2013 | n/a        |             |                         |
| II/0005   | To change the approved specification limits for the active substance. B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the limits range for the AS                         | 21/11/2013 | n/a        |             | approved specifications |

<div style=\"page-break-after: always\"></div>

| IB/0004     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                                                                                                                                                                                                                              | 20/03/2013   | 21/03/2014   | SmPC, Annex II and PL   |      |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------------------|------|
| IAIN/0003/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                                      | 14/01/2013   | n/a          |                         | site |
| IB/0002/G   | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished | 19/09/2012   | 25/10/2012   | SmPC, Labelling and PL  |      |

<div style=\"page-break-after: always\"></div>

tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g.

<div style=\"page-break-after: always\"></div>

|         | tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes   |            |            |                                  |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|
| IB/0001 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                         | 05/09/2012 | 25/10/2012 | SmPC, Annex II, Labelling and PL |